ALEXANDRA CLARK: Open Payments
NPI 1952018756 · CHRISTIANSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $170 |
| AstraZeneca Pharmaceuticals LP | 4 | $163 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $49 |
| Inspire Medical Systems, Inc. | 1 | $44 |
| Greer Laboratories, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $28 |
| Stryker Corporation | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, JOURNAVX, INSPIRE, ORALAIR, XPRESS LOPROFILE, XHANCE.
Industry payments across VA — which companies pay providers there.
